Johnson & Johnson

NYSE: JNJ
$144.77
+$0.32 (+0.2%)
Closing price April 17, 2024
Johnson & Johnson is a global healthcare giant founded in 1886, headquartered in New Brunswick, New Jersey. It operates in the healthcare sector, offering a wide range of products across various therapeutic areas including immunology, infectious diseases, neuroscience, oncology, cardiovascular, and metabolism. Additionally, it has a MedTech segment that provides interventional solutions, orthopaedics, surgery technologies, contact lenses, and intraocular lenses. The company's products are distributed worldwide to retailers, wholesalers, hospitals, and healthcare professionals, emphasizing its commitment to improving health for people everywhere.
On the cover of the Friday, April 12, 2024 edition of The Wall Street Journal, the headline read: “Cost of Owning a Home Soars”. The article cited one family whose home insurance costs had risen...
After years of a low-interest rate environment, which has reversed significantly over the last two years, many investors continue to turn to equities for growth potential and solid and dependable...
In today’s episode of the 24/7 finance series analyst Jeremy Phillips and Austin Smith discuss rebounding inflation, and two stocks for investors to look at today. In inflationary times many...
Over the last two years, interest rates have jumped from historical lows of literally 0% to the highest level since 2007 at 5.5%. 30 FHA Mortgages have jumped from 2.65% in January of 2021 to the...
The aging population and increasing life expectancy of Baby Boomers have created a growing demand for investments that provide reliable income and the potential for long-term growth. High-yield...
In the high-stakes world of investing, the late great Charlie Munger’s playbook stands out for its focus on fundamental strength and long-term value—principles that have cemented his legacy...
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Everything is starting to look rosy again. The inflation data for November came in below the estimates, earnings have been reasonably good for the third quarter, and investors just celebrated a...
The Johnson brothers started Johnson & Johnson in 1886Source: JHVEPhoto / iStock Editorial via Getty ImagesThe iconic healthcare giant was started by Robert, James, and Edward Johnson in 1886 after...
With November here, many investors are looking toward Thanksgiving, the holidays, and the end of the year. The stock market went through some of the biggest combined net selling from August to...
If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years the “Oracle of Omaha” has had a rock star-like presence in the investing world, and his annual...
Before U.S. markets open on Tuesday, these five companies are scheduled to report their quarterly earnings.
Friday's top analyst upgrades and downgrades included America Movil, Comerica, Johnson & Johnson, Monster Beverage and Shoals Technologies.
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should...